“…EndoMT is a process of nonmalignant cellular transdifferentiation by which ECs disaggregate, lose polarity, and undergo a change in their typical shape, becoming elongated and acquiring the ability to migrate into the surrounding tissue. It is a phenotypic conversion characterized by the loss of vascular EC markers such as CD31, von Willebrand factor, and VE-cadherin, and the emergence of mesenchymal cell markers such as ␣-SMA, vimentin, type I procollagen, and S100A4/fibroblastspecific protein 1 (9)(10)(11)(12).…”